These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Spinocerebellar ataxia type 3 (SCA3): thalamic neurodegeneration occurs independently from thalamic ataxin-3 immunopositive neuronal intranuclear inclusions. Rüb U; de Vos RA; Brunt ER; Sebestény T; Schöls L; Auburger G; Bohl J; Ghebremedhin E; Gierga K; Seidel K; den Dunnen W; Heinsen H; Paulson H; Deller T Brain Pathol; 2006 Jul; 16(3):218-27. PubMed ID: 16911479 [TBL] [Abstract][Full Text] [Related]
25. Parallel enlargement of Marinesco bodies and nuclei and progressive deposition of p62 in pigmented neurons of the substantia nigra. Amano R; Toru S; Yamane M; Kitagawa M; Hirokawa K; Uchihara T Neuropathology; 2020 Aug; 40(4):328-335. PubMed ID: 32202001 [TBL] [Abstract][Full Text] [Related]
26. Amyloid precursor-like protein 2 cleavage contributes to neuronal intranuclear inclusions and cytotoxicity in spinocerebellar ataxia-7 (SCA7). Takahashi-Fujigasaki J; Breidert T; Fujigasaki H; Duyckaerts C; Camonis JH; Brice A; Lebre AS Neurobiol Dis; 2011 Jan; 41(1):33-42. PubMed ID: 20732423 [TBL] [Abstract][Full Text] [Related]
27. Neuronal intranuclear inclusions are ultrastructurally and immunologically distinct from cytoplasmic inclusions of neuronal intermediate filament inclusion disease. Mosaheb S; Thorpe JR; Hashemzadeh-Bonehi L; Bigio EH; Gearing M; Cairns NJ Acta Neuropathol; 2005 Oct; 110(4):360-8. PubMed ID: 16025283 [TBL] [Abstract][Full Text] [Related]
28. Hornerin deposits in neuronal intranuclear inclusion disease: direct identification of proteins with compositionally biased regions in inclusions. Park H; Yamanaka T; Toyama Y; Fujita A; Doi H; Nirasawa T; Murayama S; Matsumoto N; Shimogori T; Ikegawa M; Haltia MJ; Nukina N Acta Neuropathol Commun; 2022 Mar; 10(1):28. PubMed ID: 35246273 [TBL] [Abstract][Full Text] [Related]
29. Interaction between neuronal intranuclear inclusions and promyelocytic leukemia protein nuclear and coiled bodies in CAG repeat diseases. Yamada M; Sato T; Shimohata T; Hayashi S; Igarashi S; Tsuji S; Takahashi H Am J Pathol; 2001 Nov; 159(5):1785-95. PubMed ID: 11696439 [TBL] [Abstract][Full Text] [Related]
30. Depletion of p62 reduces nuclear inclusions and paradoxically ameliorates disease phenotypes in Huntington's model mice. Kurosawa M; Matsumoto G; Kino Y; Okuno M; Kurosawa-Yamada M; Washizu C; Taniguchi H; Nakaso K; Yanagawa T; Warabi E; Shimogori T; Sakurai T; Hattori N; Nukina N Hum Mol Genet; 2015 Feb; 24(4):1092-105. PubMed ID: 25305080 [TBL] [Abstract][Full Text] [Related]
31. Immunohistochemical localization of exoribonucleases (DIS3L2 and XRN1) in intranuclear inclusion body disease. Mori F; Tanji K; Miki Y; Toyoshima Y; Sasaki H; Yoshida M; Kakita A; Takahashi H; Wakabayashi K Neurosci Lett; 2018 Jan; 662():389-394. PubMed ID: 29100804 [TBL] [Abstract][Full Text] [Related]
32. Optineurin immunoreactivity in neuronal nuclear inclusions of polyglutamine diseases (Huntington's, DRPLA, SCA2, SCA3) and intranuclear inclusion body disease. Mori F; Tanji K; Toyoshima Y; Yoshida M; Kakita A; Takahashi H; Wakabayashi K Acta Neuropathol; 2012 May; 123(5):747-9. PubMed ID: 22318854 [No Abstract] [Full Text] [Related]
33. SGTA associates with intracellular aggregates in neurodegenerative diseases. Kubota S; Doi H; Koyano S; Tanaka K; Komiya H; Katsumoto A; Ikeda S; Hashiguchi S; Nakamura H; Fukai R; Takahashi K; Kunii M; Tada M; Takeuchi H; Tanaka F Mol Brain; 2021 Mar; 14(1):59. PubMed ID: 33757575 [TBL] [Abstract][Full Text] [Related]
34. Neuronal intranuclear inclusion disease without polyglutamine inclusions in a child. McFadden K; Hamilton RL; Insalaco SJ; Lavine L; Al-Mateen M; Wang G; Wiley CA J Neuropathol Exp Neurol; 2005 Jun; 64(6):545-52. PubMed ID: 15977647 [TBL] [Abstract][Full Text] [Related]
35. Neuropathological staging of spinocerebellar ataxia type 2 by semiquantitative 1C2-positive neuron typing. Nuclear translocation of cytoplasmic 1C2 underlies disease progression of spinocerebellar ataxia type 2. Koyano S; Yagishita S; Kuroiwa Y; Tanaka F; Uchihara T Brain Pathol; 2014 Nov; 24(6):599-606. PubMed ID: 24674145 [TBL] [Abstract][Full Text] [Related]
36. Intranuclear inclusions, neuronal loss and CAG mosaicism in two patients with Machado-Joseph disease. Muñoz E; Rey MJ; Milà M; Cardozo A; Ribalta T; Tolosa E; Ferrer I J Neurol Sci; 2002 Aug; 200(1-2):19-25. PubMed ID: 12127671 [TBL] [Abstract][Full Text] [Related]
37. A new humanized ataxin-3 knock-in mouse model combines the genetic features, pathogenesis of neurons and glia and late disease onset of SCA3/MJD. Switonski PM; Szlachcic WJ; Krzyzosiak WJ; Figiel M Neurobiol Dis; 2015 Jan; 73():174-88. PubMed ID: 25301414 [TBL] [Abstract][Full Text] [Related]
38. Accumulation of aberrant ubiquitin induces aggregate formation and cell death in polyglutamine diseases. de Pril R; Fischer DF; Maat-Schieman ML; Hobo B; de Vos RA; Brunt ER; Hol EM; Roos RA; van Leeuwen FW Hum Mol Genet; 2004 Aug; 13(16):1803-13. PubMed ID: 15198995 [TBL] [Abstract][Full Text] [Related]
39. Autophagy and Polyglutamine Disease. Ren H; Hao Z; Wang G Adv Exp Med Biol; 2020; 1207():149-161. PubMed ID: 32671744 [TBL] [Abstract][Full Text] [Related]
40. Ubiquitin-conjugating enzyme E2-25K increases aggregate formation and cell death in polyglutamine diseases. de Pril R; Fischer DF; Roos RA; van Leeuwen FW Mol Cell Neurosci; 2007 Jan; 34(1):10-9. PubMed ID: 17092742 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]